Background Spondyloarthritis are a group of chronic inflammatory rheumatic diseases that share clinical and imaging characteristics. Sarcopenia is characterized by loss of muscle mass and function ...
Objectives To examine trends in the incidence of rheumatoid arthritis (RA) from 2005 to 2014 overall and by serological status as compared with 1995–2004 and 1985–1994. Methods We evaluated RA ...
1 Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, Shinjuku-ku, Tokyo, Japan 2 Department of Medicine and Rheumatology, Graduate School of Tokyo Medical ...
Background Since the publication of the EULAR recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several randomised clinical trials ...
Professor D L Scott, King's College Hospital, East Dulwich Grove, Dulwich, London SE22 8PT, UKleigh.joyce{at}kcl.ac.uk OBJECTIVE Recent studies have demonstrated the short term efficacy of leflunomide ...
The aim was to update the 2009 European League against Rheumatism (EULAR) recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic questions. Update of the ...
1 Departments of Infectious Diseases (KLW), Public Health and Preventive Medicine (DC, KLW, DA), Ophthalmology (EBS, JTR, KLW, CDV), and Rheumatology (JTR), Oregon Health & Science University, ...
Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands Professor R Landewé, Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical ...
Objective This observational cohort study investigated the impact of biological (b) disease-modifying antirheumatic drugs (DMARDs) on the outcomes of serious infections (SIs) in patients with ...
Background High serum uric acid (sUA) has been associated with increased mortality risks, but its clinical treatment varied with potential side effects. The role of physical activity has received ...
Objective: To create minimal disease activity (MDA) criteria for psoriatic arthritis (PsA). With recent therapeutic advances, this is now a goal for treatment and may represent a measure to compare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results